01/26/2024 / By Zoey Sky
Deaths and injuries linked to vaccines were not only observed after the mass Wuhan coronavirus (COVID-19) vaccination during the pandemic. In fact, there are records of severe adverse events since the first vaccines in human history were developed.
The history of smallpox vaccination, which dates back to the late 18th century, is full of various accounts of adverse effects and complications.
These severe complications include progressive vaccinia, an infection caused by the vaccine virus itself, eczema vaccinatum and encephalitis, which are rare.
Official records from England from 1859 to 1921, like those documented by J.T. Biggs in the 1912 book “Leicester: Sanitation versus Vaccination,” show that there is an alarming trend of vaccination-related complications that resulted in an estimated 1,530 deaths directly linked to the smallpox vaccine.
For example, from 1906 to 1922, the mortality rates from both smallpox and vaccination-related deaths were similar.
A table from the Annual Returns of the Registrar-General, as recorded in Biggs’ book, was considered an indicator instead of a comprehensive record. The table omitted permanent or severe injuries.
According to the table, due to the enforcement of vaccination, the designation of the adverse events post-vaccination was limited to “cowpox” from 1898 through 1910.
Additionally, the causality of the smallpox vaccine in these death cases was strengthened by an 1897 report referring to the 36 deaths reported for that year as directly attributed to the effects of smallpox vaccination. The cause of death was either stated in the medical certificate or was confirmed by investigation.
The vaccine’s potential to cause serious harm was highlighted by specific cases of erysipelas, a severe form of skin infection that caused a painful and prolonged death. Instances included a 13-week-old infant succumbing to “general erysipelas after vaccination” and a four-month-old girl dying from the same condition post-vaccination.
These cases were not isolated incidents but were part of a broader pattern of severe reactions to the smallpox vaccine, which experts say could have been caused by the various pathogens the vaccine carried that caused severe skin infections. (Related: Dr. Jane Ruby: Americans are still in DANGER from the mRNA shots.)
Eczema vaccinatum, another severe condition linked to the vaccine, was further evidence of the risks linked to smallpox immunization.
In one case, a 15-month-old boy passed away after developing this condition following his vaccination. This could have been caused by the inflammatory cytokines in those alleged “pure lymph” or other types of smallpox vaccines.
While uncommon, encephalitis following vaccination often causes fatalities, especially in vaccinated babies and young children. The death rate in reported cases varies between nine to an alarming 40 percent.
While there are survivors, 10 to 25 percent of those who survive encephalitis suffer from lasting neurological damage.
Researchers who conducted a 2003 systematic review of the risk for serious complications and death from smallpox vaccination in the U.S. from 1963 to 1968 reported that post-vaccinial encephalitis and vaccinia necrosum had life-threatening complication rates of at least three per million and one per million primary vaccinations, respectively.
The death rate was 29 percent for post-vaccinial encephalitis and 15 percent for vaccinia necrosum cases.
Like smallpox vaccine issues, current COVID-19 vaccine issues include negative side effects often attributed to the components of the vaccine, including autoimmune diseases, blood clots, brain bleeds, myocarditis, pericarditis and aggressive cancers.
Based on modern vaccine quality standards, there are usually valid reasons to challenge the safety and efficacy of the smallpox vaccine.
The modern smallpox vaccine has undergone three generations of development. The first and second generations of the smallpox vaccine, which was first developed between the 1950s and 1970s, used original live viruses grown on animal skin or in cell cultures.
These versions had a higher risk of severe or life-threatening side effects, including one to two fatalities per million vaccinations, three to nine cases of postvaccinal encephalitis (PVE), one to seven instances of progressive vaccinia, and two to 35 cases of eczema vaccinatum.
Because the viruses included in the smallpox vaccine were still alive, they needed to be maintained in lab animals and cell cultures. Not everyone knows that modern smallpox vaccines have a complex 70-year history of passage in various laboratory animals, including mice, rabbits, goats and cows, to make the modern attenuated smallpox vaccines.
This may be the first known example in human history of the initial types of laboratory manipulation of a virus later used for vaccination.
To illustrate, the most widely used Dryvax vaccine was from calf lymph derived from the New York City Board of Health strain. Dryvax, a vaccine licensed in the U.S., is a lyophilized (freeze-dried), live-virus preparation of the infectious vaccinia virus, which is considered to have a crucial role in eradicating smallpox.
Third-generation vaccines use attenuated strains of vaccinia and had limited usage before smallpox eradication. These vaccines have relatively milder side effects due to weakened virus strains, eventually replacing Dryvax.
In the late 1990s, scientists studying the genetic components of vaccines using advanced gene sequencing tools found out that Dryvax was more complex than previously thought.
The study findings suggested that Dryvax was made up of different viruses. The sequencing identified an evolving mutation pattern, which showed that some genes were highly fragmented while others were disrupted in specific strains.
The study highlighted the complex nature of the Dryvax vaccine and pointed out the significant impact of human laboratory interventions on orthopoxvirus populations, or viruses that cause poxvirus diseases like cowpox, monkeypox and smallpox.
Modern smallpox vaccines don’t include cowpox or smallpox virus but are a hybrid human and animal agent that never existed in nature until the era of vaccination.
This is similar to the COVID-19 pandemic and the significant impact of human research on the evolution of wild-type viruses, drawing parallels to the origin of the SARS-CoV-2 virus that caused the coronavirus pandemic.
Big Pharma and mainstream media continue to claim that the smallpox vaccine was a life-saving medical invention. However, studying the historical data reveals a troubling story of the disease’s prevalence and mortality, as well as the adverse effects of the vaccine.
Unfortunately, this false narrative was developed for more than hundreds of years. Propagating such a narrative is also easier when there is limited access to historical documentation of deaths and injuries after smallpox vaccination.
Additionally, this has made studying the causal relationships between the natural smallpox waves and the vaccination campaigns almost impossible. At the same time, people usually trust public health authorities who have made this the official narrative.
The same thing happened with Big Pharma and mainstream media’s COVID-19 narrative, which has been easier to propagate with control over mainstream media.
Watch the video below to learn more about viral delusion and diseases like AIDS, polio, smallpox and COVID-19.
This video is from the Tammy Cuthbert Garcia channel on Brighteon.com.
BE AFRAID: The next pandemic could be more contagious and deadlier than COVID-19, say “experts.”
Study links Pfizer’s COVID-19 vaccine to VAIDS in children.
Dr. John Coleman: Club of Rome responsible for SATANIC depopulation and transhumanist agendas.
Sources include:
Tagged Under:
big government, Big Pharma, biological weapon, children's health, covid-19, immune health, immune system, pandemic, pharmaceutical fraud, real investigations, research, smallpox, smallpox vaccines, spike protein, truth, vaccine damage, vaccine injury, vaccines
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 BIO TECH NEWS